The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--SAGE Therapeutics (SAGE), a biopharmaceutical company developing novel medicines to treat life-threatening, rare central nervous system (CNS) disorders, today ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sage Therapeutics, Inc. (Nasdaq: SAGE), today announced plans to reorganize its business operations and pipeline priorities to support goals for long-term business ...

Office owner Sage’s centennial celebration has come and gone, and while CEO and President Jonathan Iger might not know where he wants Sage to be in another 100 years, he certainly knows where he wants ...

Sage Therapeutics cut more than half of its workforce in a restructuring move that slams postpartum drug Zulresso and the sales team promoting it. The estimated 340 employees laid off primarily worked ...

DALLAS, November 20, 2025--(BUSINESS WIRE)--Trinity Hunt Partners, a growth-oriented private equity firm, is pleased to announce the establishment of its commercial paving services platform under the ...

Sage has announced new tools and commercial options designed to make it easier for developers and partners to build, launch and scale solutions across Sage products. The update introduces a more ...

The MarketWatch News Department was not involved in the creation of this content. Ormat Technologies and Carbon Direct Capital co-lead Series B financing, which will support the development of Sage's ...

Strengthened financial position with expected annualized net savings of approximately $240 million anticipated to extend cash runway into 2026 CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Sage Therapeutics, ...